Nanostructured Silver–Collagen Platforms in Clinical Practice: Bridging Innovation Towards Next-Generation Wound Care Products
Journal of Functional Biomaterials · 16.11.2026 · 17 (11) · 581
DOI: 10.3390/jfb17110581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 16.11.2026. Verfasst von Nadezhda A. Pechnikova und 11 weiteren Autor:innen. Die Arbeit nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Wound healing remains challenging, especially in chronic or infected lesions where standard dressings rarely restore full tissue integrity. Silver nanoparticles (AgNPs) have gained attention because they combine broad-spectrum antimicrobial activity with anti-inflammatory and pro-regenerative effects. Simultaneously, natural biopolymers like collagen and gelatin (key dermal extracellular matrix proteins) support tissue regeneration by promoting fibroblast infiltration, neovascularization, and granulation tissue formation. This review examines how integrating AgNPs with collagen creates combined beneficial effects in clinical practice that lead to multifunctional commercial dressings that exert infection control with advanced tissue repair and regulate silver release while maintaining a moist, hemostatic microenvironment. Preclinical studies support the potential of selected AgNP–collagen and AgNP–gelatin constructs to combine antimicrobial activity with matrix-supported repair, whereas clinical evidence is more extensive for the broader class of silver-containing dressings and some collagen/oxidized regenerated cellulose–silver products than for nanoparticle-decorated collagen systems specifically. Commercial and pipeline products, supported by clinical trials, validate the efficacy of AgNP–collagen dressings in the clinic. Key limitations that restrict their widespread use include limited commercialization potential based on small companies, microbial resistance and insufficient characterization of AgNPs, raising irreproducibility, toxicity and regulatory issues. Overall, nanostructured silver–collagen platforms can play a significant role in innovation towards next-generation wound care products.
Zitieren
APA
Pechnikova, N. A., Yaremenko, A. V., Ntolia, A., Kalis, M., Manglaris, C., Varlamis, S., Choli-Papadopoulou, T., Diakakis, N., Zaspalis, V., Papazoglou, L. G., Michailidis, N., & Aggeli, A. (2026). Nanostructured Silver–Collagen Platforms in Clinical Practice: Bridging Innovation Towards Next-Generation Wound Care Products. Journal of Functional Biomaterials, 17(11), 581. https://doi.org/10.3390/jfb17110581
Vancouver
Pechnikova NA, Yaremenko AV, Ntolia A, Kalis M, Manglaris C, Varlamis S, et al. Nanostructured Silver–Collagen Platforms in Clinical Practice: Bridging Innovation Towards Next-Generation Wound Care Products. Journal of Functional Biomaterials. 2026;17(11):581. doi:10.3390/jfb17110581
BibTeX
@article{Pechnikova2026,
author = {Pechnikova, Nadezhda A. and Yaremenko, Alexey V. and Ntolia, Anastasia and Kalis, Michail and Manglaris, Chris and Varlamis, Sotirios and Choli-Papadopoulou, Theodora and Diakakis, Nikolaos and Zaspalis, Vasilios and Papazoglou, Lysimachos G. and Michailidis, Nikolaos and Aggeli, Amalia},
title = {Nanostructured Silver–Collagen Platforms in Clinical Practice: Bridging Innovation Towards Next-Generation Wound Care Products},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {11},
pages = {581},
doi = {10.3390/jfb17110581}
}
EUVIMED